Much work is needed to address inequities and gaps in care access for patients with acute myeloid leukemia (AML ... or refractory diffuse large B-cell lymphoma (DLBCL) that recently received ...

Venetoclax is under clinical development by AbbVie and currently in Phase II for Refractory Acute Myeloid Leukemia. According to GlobalData, Phase II drugs for Refractory Acute Myeloid Leukemia have a ...

Lee Greenberger, PhD, has retired as The Leukemia & Lymphoma Society’s chief scientific officer after more than a decade in ...

Acute Myeloid Leukaemia (AML) with Retinoic acid receptor-gamma (RARG) fusions have similarities to Acute Promyelocytic Leukemia (APL) but are not responsive to standard APL treatments.

Information on treatment success rates for AML in adults can be found in Treatment Response Rates for Acute Myeloid Leukemia. Our team is made up of doctors and oncology certified nurses with deep ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

Two posters presented at the 2024 American Society of Hematology meeting reported real-world outcomes data for patients ...

1Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

Environmental toxins like pesticides and heavy metals can lead to blood cancer. Learn how genetics, lifestyle, and exposure ...

Treatment response rates for acute myeloid leukemia (AML). National Library of Medicine: DailyMed. Scemblix—asciminib tablet, film coated [drug label]. Chopade P, Akard LP. Improving outcomes in ...